NMT Group sets up US office to launch Zero-Stick:
This article was originally published in Clinica
NMT Group has set up a US office in order to commercialise its needle retraction technology, Zero-Stick, in the US. The establishment of New Medical Technology coincides with the introduction of a bill calling for new legislation requiring hospitals to use safe needle products. The Scottish company, which is listed on the Alternative Investment Market of the London Stock Exchange, says that more than 1 million needlestick injuries are reported annually in the US, resulting in over 300 deaths a year.